annual current liabilities:
$80.61M+$43.68M(+118.25%)Summary
- As of today (May 23, 2025), TARS annual total current liabilities is $80.61 million, with the most recent change of +$43.68 million (+118.25%) on December 31, 2024.
- During the last 3 years, TARS annual current liabilities has risen by +$69.13 million (+602.32%).
- TARS annual current liabilities is now at all-time high.
Performance
TARS Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$86.31M+$5.70M(+7.07%)Summary
- As of today (May 23, 2025), TARS quarterly total current liabilities is $86.31 million, with the most recent change of +$5.70 million (+7.07%) on March 31, 2025.
- Over the past year, TARS quarterly current liabilities has increased by +$43.78 million (+102.94%).
- TARS quarterly current liabilities is now at all-time high.
Performance
TARS quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TARS Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +118.3% | +102.9% |
| 3 y3 years | +602.3% | +584.4% |
| 5 y5 years | +9742.7% | - |
TARS Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +602.3% | at high | +636.5% |
| 5 y | 5-year | at high | +9742.7% | at high | +2706.8% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
TARS Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $86.31M(+7.1%) |
| Dec 2024 | $80.61M(+118.2%) | $80.61M(+22.4%) |
| Sep 2024 | - | $65.87M(+27.7%) |
| Jun 2024 | - | $51.57M(+21.3%) |
| Mar 2024 | - | $42.53M(+15.1%) |
| Dec 2023 | $36.94M(+139.4%) | $36.94M(+58.9%) |
| Sep 2023 | - | $23.25M(+57.5%) |
| Jun 2023 | - | $14.77M(+11.4%) |
| Mar 2023 | - | $13.26M(-14.1%) |
| Dec 2022 | $15.43M | $15.43M(+8.1%) |
| Sep 2022 | - | $14.27M(+21.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $11.72M(-7.1%) |
| Mar 2022 | - | $12.61M(+9.9%) |
| Dec 2021 | $11.48M(+113.1%) | $11.48M(+10.7%) |
| Sep 2021 | - | $10.37M(-0.9%) |
| Jun 2021 | - | $10.46M(+3.3%) |
| Mar 2021 | - | $10.12M(+87.8%) |
| Dec 2020 | $5.39M(+557.8%) | $5.39M(-12.3%) |
| Sep 2020 | - | $6.14M(+99.8%) |
| Jun 2020 | - | $3.08M(+275.5%) |
| Dec 2019 | $819.00K(+357.5%) | $819.00K |
| Dec 2018 | $179.00K | - |
FAQ
- What is Tarsus Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual current liabilities year-on-year change?
- What is Tarsus Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly current liabilities year-on-year change?
What is Tarsus Pharmaceuticals annual total current liabilities?
The current annual current liabilities of TARS is $80.61M
What is the all time high annual current liabilities for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual total current liabilities is $80.61M
What is Tarsus Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, TARS annual total current liabilities has changed by +$43.68M (+118.25%)
What is Tarsus Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of TARS is $86.31M
What is the all time high quarterly current liabilities for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly total current liabilities is $86.31M
What is Tarsus Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, TARS quarterly total current liabilities has changed by +$43.78M (+102.94%)